Skip to main content

JPMORGAN CHASE & CO

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in APLS

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
2,047,927
+1198.2% QoQ
Ownership
1.60%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 2,047,927
2025-12-31 157,754
2025-09-30 53,516
2025-06-30 234,801
2025-03-31 423,800
2024-12-31 411,549
2024-09-30 3,884,730
2024-06-30 3,177,470
2024-03-31 2,214,309
2023-12-31 2,574,133
2023-09-30 2,217,747
2023-06-30 1,786,982
2023-03-31 1,648,452
2022-12-31 1,847,309
2022-09-30 940,047
2022-06-30 1,073,965
2022-03-31 1,266,238
2021-12-31 1,587,878
2021-09-30 1,533,142
2021-06-30 415,093
2021-03-31 436,280
2020-12-31 631,632
2020-09-30 703,405
2020-06-30 101,139
2020-03-31 76,835